Gut epithelial barrier and systemic inflammation during chronic HIV infection
- 2 January 2015
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 29 (1) , 43-51
Abstract
Objective: Microbial translocation and innate immune action characterize HIV infection. Continued gut mucosal dysfunction during treatment and its relationship to CD4+ T-cell recovery has not been well described. Design: A cross-sectional study was performed of antiretroviral therapy (ART)-suppressed (immunologic responders with CD4+ > 500 cells/μl and immunologic nonresponders with CD4+ < 350 cells/μl), untreated HIV-infected, and seronegative participants consenting to gut biopsies and a blood draw. Methods: Neutrophil infiltration as a surrogate response to epithelial breach, colorectal epithelial proliferation as a measure of repair, and mucosal apoptosis by immunohistochemistry were determined in gut biopsies. Plasma markers of monocyte activation (sCD14), immune activation (interleukin-6), and indoleamine 2,3-dioxygenase-1 activity (plasma kynurenine/tryptophanratio) were concurrently measured. Results: Each HIV-infected group had greater neutrophil infiltration than controls. Similarly, untreated HIV-infected participants and ART-suppressed immunologic responders had increased epithelial proliferation compared with controls, but immunologic nonresponders had no appreciable increase in epithelial proliferation despite elevated neutrophil infiltration. The CD4+ T-cell count was positively correlated with epithelial proliferation and was modestly negatively correlated with neutrophil infiltration in ART-suppressed patients. Epithelial proliferation was inversely correlated with mucosal apoptosis, and apoptosis was linked to plasma sCD14 and modestly to kynurenine/tryptophan ratio. Conclusions: Neutrophil infiltration and mucosal apoptosis remain abnormally high despite ART. Epithelial proliferation increases in HIV, but may be impaired in immunologic nonresponders. Whether mucosal apoptosis is a cause or consequence of epithelial proliferative defects is unclear, but appears to be associated with systemic inflammation. The impact of ART and interventions targeting the gut epithelial barrier in treated HIV infection warrant further investigation.Keywords
This publication has 42 references indexed in Scilit:
- Early microbial translocation blockade reduces SIV-mediated inflammation and viral replicationJournal of Clinical Investigation, 2014
- Decreases in Colonic and Systemic Inflammation in Chronic HIV Infection after IL-7 AdministrationPLOS Pathogens, 2014
- Pathogenic Simian Immunodeficiency Virus Infection Is Associated with Expansion of the Enteric ViromeCell, 2012
- Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapyAIDS, 2011
- Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 CellsThe Journal of Infectious Diseases, 2011
- Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus InfectionsPLOS Pathogens, 2010
- Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infectionMucosal Immunology, 2010
- Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patientsGut, 2008
- Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesThe Lancet, 2008
- Rapid Onset of Intestinal Epithelial Barrier Dysfunction in Primary Human Immunodeficiency Virus Infection Is Driven by an Imbalance between Immune Response and Mucosal Repair and RegenerationJournal of Virology, 2008